Back to HomeBeta

ICD-10 Coding for Primary Myelofibrosis(D47.4, D75.81)

Complete ICD-10-CM coding and documentation guide for Primary Myelofibrosis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Chronic Idiopathic MyelofibrosisAgnogenic Myeloid Metaplasia

Related ICD-10 Code Ranges

Complete code families applicable to Primary Myelofibrosis

D47-D47.9Primary Range

Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue

This range includes codes for chronic myeloproliferative diseases, including primary myelofibrosis.

Other and unspecified diseases of blood and blood-forming organs

This range includes codes for secondary myelofibrosis and other related conditions.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D47.4OsteomyelofibrosisUse for confirmed cases of primary myelofibrosis with appropriate clinical documentation.
  • Bone marrow biopsy showing fibrosis grade ≥2
  • Presence of JAK2, CALR, or MPL mutations
  • Exclusion of other myeloid neoplasms
D75.81MyelofibrosisUse for secondary myelofibrosis or when primary status is not specified.
  • Documentation of secondary cause or unspecified myelofibrosis

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for primary myelofibrosis

Essential facts and insights about Primary Myelofibrosis

The ICD-10 code for primary myelofibrosis is D47.4, which includes chronic idiopathic myelofibrosis.

Primary ICD-10-CM Codes for primary myelofibrosis

Osteomyelofibrosis
Billable Code

Decision Criteria

clinical Criteria

  • Presence of JAK2, CALR, or MPL mutations

documentation Criteria

  • Bone marrow biopsy showing fibrosis grade ≥2

coding Criteria

  • Exclusion of other myeloid neoplasms

Applicable To

  • Chronic idiopathic myelofibrosis
  • Primary myelofibrosis

Excludes

  • Acute myelofibrosis (C94.4)

Clinical Validation Requirements

  • Bone marrow biopsy showing fibrosis grade ≥2
  • Presence of JAK2, CALR, or MPL mutations
  • Exclusion of other myeloid neoplasms

Code-Specific Risks

  • Misclassification as secondary myelofibrosis
  • Lack of specific mutation documentation

Coding Notes

  • Ensure documentation specifies 'primary' or 'idiopathic' to use D47.4.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Fever, unspecified

R50.9
Use for constitutional symptoms like fever associated with myelofibrosis.

Anemia, unspecified

D64.9
Use when anemia is present and requires transfusion support.

Splenomegaly, not elsewhere classified

R16.1
Use when splenomegaly is confirmed by imaging or physical exam.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Myelofibrosis

D75.81
Use D75.81 for secondary myelofibrosis or when primary status is not specified.

Osteomyelofibrosis

D47.4
Use D47.4 for confirmed primary myelofibrosis cases.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Primary Myelofibrosis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D47.4.

Impact

Clinical: Leads to potential misclassification of the condition., Regulatory: Non-compliance with coding specificity requirements., Financial: May affect reimbursement due to incorrect DRG assignment.

Mitigation Strategy

Always specify 'primary' or 'secondary' in documentation., Query provider if documentation is unclear.

Impact

Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Query provider to confirm 'primary' vs. 'secondary' etiology.

Impact

Using D75.81 for primary myelofibrosis cases.

Mitigation Strategy

Implement regular training on distinguishing primary vs. secondary myelofibrosis.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Primary Myelofibrosis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Primary Myelofibrosis

Use these documentation templates to ensure complete and accurate documentation for Primary Myelofibrosis. These templates include all required elements for proper coding and billing.

Primary Myelofibrosis Diagnosis

Specialty: Hematology

Required Elements

  • Bone marrow biopsy findings
  • Mutation status
  • Splenomegaly assessment

Example Documentation

56M with primary myelofibrosis (JAK2+), grade 3 collagen fibrosis on trichrome stain, leukoerythroblastosis, and splenomegaly (18 cm). Anemia (Hb 8.2 g/dL) requiring biweekly transfusions.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Myelofibrosis with anemia.
Good Documentation Example
Hypercellular marrow with megakaryocytic proliferation, grade 2 reticulin fibrosis, JAK2 V617F mutation detected.
Explanation
The good example provides specific clinical details and mutation status necessary for accurate coding.

Need help with ICD-10 coding for Primary Myelofibrosis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more